About Julie Grant
Julie Grant is a director at Nocion Therapeutics.
Julie Grant first appears on SEC filings in 2021.
Experience
This experience comes from Julie Grant's profile and from SEC filings. For roles taken from filings, the years are when the filings name Julie Grant in the role, so the role may have started earlier or lasted longer.
SY
Synthekine Current
Board Member
2019 – Present
Nocion Therapeutics, Inc. Current
Director
2018 – Present · Watertown, MA
Develops inhaled medicines for people with chronic cough.
CA
Canaan Current
General Partner (2014 – Present)
Associate (2013 – 2014)
2013 – Present
DB
Day One Biopharmaceuticals
Chair Of The Board Of Directors
2018 – 2023
GL
Glooko
Board Observer
2015 – 2019
BI
Biden Cancer Initiative
Board Member
2017 – 2018
CT
Chrono Therapeutics
Board Observer
2014 – 2018
PT
Protagonist Therapeutics
Board Member
2015 – 2017
CT
CytomX Therapeutics
Board Observer
2013 – 2015
CR
Cellular Research
Seed Investor and Board Observer
2013 – 2015
AP
ALDEA Pharma
Board Observer
2013 – 2015
DI
Dermira, Inc.
Board Observer
2013 – 2014
LI
LABRYS BIOLOGICS, INC.
Board Observer
2013 – 2014
GE
Genentech
Market Planning Manager - BioOncology New Products Lead
2006 – 2011
YR
Yale University Office of Cooperative Research
Licensing Intern
2005
GS
Goldman Sachs
Summer Analyst, Americas Special Situations Group
2004
Key Colleagues at Startups
The people Julie Grant works with at each company, as listed on that company's latest Form D.
Nocion Therapeutics, Inc. · Form D, Mar 13, 2026
VM
Vijay Murthy
Director
PO
Pini Orbach
Director
RH
Rosy Hu
Director
Matthew Frankel
Chief Medical Officer
Peter Courossi
Acting Chief Financial Officer
Richard Batycky
President and Chief Executive Officer, director
JE
James Ellis
Chief Scientific Officer
FD
Freddie Dear
Director
MH
Michael Higgins
Director